| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T671 |
16-29 |
GO:0065007 |
denotes |
Dysregulation |
| T672 |
40-50 |
SP_7 |
denotes |
SARS-CoV-2 |
| T673 |
66-70 |
PR:000001393 |
denotes |
IL-6 |
| T674 |
104-109 |
UBERON:0001977 |
denotes |
serum |
| T675 |
121-125 |
PR:000001393 |
denotes |
IL-6 |
| T723 |
136-147 |
SP_7 |
denotes |
solute numb |
| T724 |
163-167 |
PR:000001393 |
denotes |
DR o |
| T676 |
169-173 |
PR:000001889 |
denotes |
CD14 |
| T677 |
174-183 |
CL:0000576 |
denotes |
monocytes |
| T725 |
201-206 |
UBERON:0001977 |
denotes |
rs) c |
| T726 |
218-222 |
PR:000001393 |
denotes |
of c |
| T727 |
265-269 |
PR:000001889 |
denotes |
rovi |
| T728 |
270-279 |
CL:0000576 |
denotes |
ed.
(B) C |
| T678 |
311-321 |
CL:0000542 |
denotes |
lymphocyte |
| T679 |
367-371 |
PR:000001889 |
denotes |
CD14 |
| T680 |
372-381 |
CL:0000576 |
denotes |
monocytes |
| T729 |
408-418 |
CL:0000542 |
denotes |
rrelation |
| T730 |
463-467 |
PR:000001889 |
denotes |
Chan |
| T731 |
468-477 |
CL:0000576 |
denotes |
es of the |
| T681 |
509-513 |
PR:000001889 |
denotes |
CD14 |
| T682 |
514-523 |
CL:0000576 |
denotes |
monocytes |
| T683 |
553-563 |
SP_7 |
denotes |
SARS-CoV-2 |
| T684 |
591-597 |
UBERON:0002405 |
denotes |
immune |
| T732 |
606-610 |
PR:000001889 |
denotes |
on a |
| T733 |
611-620 |
CL:0000576 |
denotes |
ter incub |
| T685 |
648-654 |
UBERON:0001969 |
denotes |
plasma |
| T734 |
650-660 |
SP_7 |
denotes |
asma.
(D) |
| T686 |
675-678 |
GO:0005675 |
denotes |
MFI |
| T687 |
682-685 |
PR:000029150 |
denotes |
HLA |
| T735 |
688-693 |
UBERON:0002405 |
denotes |
on C |
| T688 |
692-696 |
PR:000001889 |
denotes |
CD14 |
| T689 |
697-706 |
CL:0000576 |
denotes |
monocytes |
| T690 |
736-746 |
SP_7 |
denotes |
SARS-CoV-2 |
| T736 |
744-750 |
UBERON:0001969 |
denotes |
-2 wit |
| T737 |
771-774 |
GO:0005675 |
denotes |
of |
| T691 |
774-780 |
UBERON:0002405 |
denotes |
immune |
| T738 |
779-782 |
PR:000029150 |
denotes |
e a |
| T739 |
789-793 |
PR:000001889 |
denotes |
on a |
| T740 |
794-803 |
CL:0000576 |
denotes |
ter incub |
| T692 |
831-837 |
UBERON:0001969 |
denotes |
plasma |
| T741 |
833-843 |
SP_7 |
denotes |
asma.
(E) |
| T742 |
872-877 |
UBERON:0002405 |
denotes |
rs of |
| T693 |
889-893 |
PR:000001889 |
denotes |
CD14 |
| T694 |
894-903 |
CL:0000576 |
denotes |
monocytes |
| T743 |
928-934 |
UBERON:0001969 |
denotes |
ed by |
| T695 |
934-944 |
SP_7 |
denotes |
SARS-CoV-2 |
| T696 |
950-956 |
UBERON:0002405 |
denotes |
immune |
| T697 |
957-970 |
GO:0065007 |
denotes |
dysregulation |
| T744 |
986-990 |
PR:000001889 |
denotes |
n wi |
| T745 |
991-1000 |
CL:0000576 |
denotes |
h medium |
| T698 |
1010-1016 |
UBERON:0001969 |
denotes |
plasma |
| T699 |
1018-1028 |
GO:0065007 |
denotes |
modulation |
| T746 |
1031-1041 |
SP_7 |
denotes |
the addit |
| T747 |
1047-1052 |
UBERON:0002405 |
denotes |
the |
| T748 |
1053-1066 |
GO:0065007 |
denotes |
pecific IL-6 |
| T700 |
1061-1065 |
PR:000001393 |
denotes |
IL-6 |
| T701 |
1074-1085 |
DG_35 |
denotes |
Tocilizumab |
| T749 |
1106-1112 |
UBERON:0001969 |
denotes |
hanges |
| T750 |
1114-1124 |
GO:0065007 |
denotes |
f the MFI |
| T702 |
1127-1130 |
PR:000029150 |
denotes |
HLA |
| T703 |
1137-1141 |
PR:000001889 |
denotes |
CD14 |
| T704 |
1142-1151 |
CL:0000576 |
denotes |
monocytes |
| T751 |
1157-1161 |
PR:000001393 |
denotes |
ght |
| T752 |
1170-1181 |
DG_35 |
denotes |
infected by |
| T705 |
1182-1192 |
SP_7 |
denotes |
SARS-CoV-2 |
| T706 |
1198-1204 |
UBERON:0002405 |
denotes |
immune |
| T707 |
1205-1218 |
GO:0065007 |
denotes |
dysregulation |
| T753 |
1224-1227 |
PR:000029150 |
denotes |
in |
| T754 |
1234-1238 |
PR:000001889 |
denotes |
n wi |
| T755 |
1239-1248 |
CL:0000576 |
denotes |
h medium |
| T708 |
1258-1264 |
UBERON:0001969 |
denotes |
plasma |
| T709 |
1266-1276 |
GO:0065007 |
denotes |
modulation |
| T756 |
1279-1289 |
SP_7 |
denotes |
the addit |
| T757 |
1295-1300 |
UBERON:0002405 |
denotes |
the |
| T758 |
1301-1314 |
GO:0065007 |
denotes |
pecific IL-6 |
| T710 |
1309-1313 |
PR:000001393 |
denotes |
IL-6 |
| T711 |
1322-1333 |
DG_35 |
denotes |
tocilizumab |
| T759 |
1354-1360 |
UBERON:0001969 |
denotes |
hanges |
| T760 |
1362-1372 |
GO:0065007 |
denotes |
f the abso |
| T712 |
1377-1387 |
CL:0000542 |
denotes |
lymphocyte |
| T761 |
1405-1409 |
PR:000001393 |
denotes |
ents |
| T762 |
1418-1429 |
DG_35 |
denotes |
nd after st |
| T713 |
1451-1462 |
DG_35 |
denotes |
Tocilizumab |
| T714 |
1468-1481 |
GO:0005622 |
denotes |
Intracellular |
| T763 |
1473-1483 |
CL:0000542 |
denotes |
cellular s |
| T715 |
1495-1499 |
PR:000001393 |
denotes |
IL-6 |
| T716 |
1503-1507 |
PR:000001889 |
denotes |
CD14 |
| T717 |
1508-1517 |
CL:0000576 |
denotes |
monocytes |
| T718 |
1525-1528 |
PR:000001004 |
denotes |
CD4 |
| T719 |
1529-1540 |
CL:0000542 |
denotes |
lymphocytes |
| T764 |
1547-1558 |
DG_35 |
denotes |
ee patients |
| T765 |
1564-1577 |
GO:0005622 |
denotes |
ted by SARS-C |
| T720 |
1571-1581 |
SP_7 |
denotes |
SARS-CoV-2 |
| T721 |
1587-1593 |
UBERON:0002405 |
denotes |
immune |
| T766 |
1592-1596 |
PR:000001393 |
denotes |
e dy |
| T722 |
1594-1607 |
GO:0065007 |
denotes |
dysregulation |
| T767 |
1600-1604 |
PR:000001889 |
denotes |
ulat |
| T768 |
1605-1614 |
CL:0000576 |
denotes |
on.
Stati |
| T769 |
1622-1625 |
PR:000001004 |
denotes |
omp |
| T770 |
1626-1637 |
CL:0000542 |
denotes |
risons are |
| T771 |
1668-1678 |
SP_7 |
denotes |
n-signific |
| T772 |
1684-1689 |
UBERON:0002405 |
denotes |
p < 0 |
| T773 |
1690-1703 |
GO:0065007 |
denotes |
05; ∗∗p < 0.0 |
